A Study to Evaluate the Relationship of Lenalidomide With Tumor Flare Reaction and High Tumor Burden in Participants With Relapsed or Refractory Mantle Cell Lymphoma
NCT ID: NCT03647124
Last Updated: 2025-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
105 participants
OBSERVATIONAL
2019-03-13
2024-01-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma
NCT01724177
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
NCT00963105
Lenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT01246622
Lenalidomide In Patients With Acute Myeloid Leukemia
NCT00839059
Lenalidomide in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT00439231
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lenalidomide treated Relapsed or refractory mantle cell lymphoma (R/R-MCL) participants in Europe
Lenalidomide
Specified dose on specified days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lenalidomide
Specified dose on specified days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Informed consent of the patient or an authorized third person or authority, if required by law, given prior to data collection.
Patient must be ≥18 years of age at the time of signing the informed consent form.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Celgene
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Bristol-Myers Squibb
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institution: Hopital Prive du Confluent
Nantes, , France
Local Institution - 308
Nantes, , France
Local Institution - 105
Graz, , Austria
LKH Graz Medizinische Universitätsklinik
Graz, , Austria
LKH Hochsteiermark, Standort Leoben
Leoben, , Austria
Local Institution - 104
Leoben, , Austria
Local Institution - 102
Salzburg, , Austria
Salzburger Landeskliniken - Universitaetsklinikum Salzburg
Salzburger, , Austria
AKH Wien, Universitaetsklinik fuer Innere Medizin III
Vienna, , Austria
Local Institution - 101
Vienna, , Austria
Landesklinikum Wiener Neustadt
Wiener Neustadt, , Austria
Local Institution - 103
Wiener Neustadt, , Austria
Centre Hospitalier de Versailles André Mignot
Le Chesnay, , France
Local Institution - 303
Le Chesnay, , France
Assistance Publique - Hopitaux de Paris (AP-HP) - Hopital Universitaire Pitie Salpetriere (Hopital Pitie-Salpetriere)
Paris, , France
Centre Hospitalier de Saint-Quentin
Saint Quentin Picardie, , France
Institut Universitaire du Cancer Toulouse - Oncopole
Toulouse, , France
Local Institution - 305
Toulouse, , France
Berufsausuebungsgemeinschaft Kiehl/Stein
Frankfurt/ Oder Brandenburg, , Germany
Praxis fuer Haematolgie, Onkologie und Palliativmedizin
Leipzig, , Germany
Local Institution - 256
Würzburg, , Germany
Universitaetsklinikum Wuerzburg
Würzburg, , Germany
General University Hospital of Alexandroupolis
Alexandrouppoli, , Greece
General Anti-Cancer Hospital "Agios Savvas"
Athens, , Greece
Local Institution - 501
Athens, , Greece
Private hospital "Iatriko Psychikou", Athens
Athens, , Greece
General University Hospital of Athens "LAIKO", Athens
Athens, , Greece
Local Institution - 502
Athens, , Greece
Local Institution - 506
Athens Goudi, , Greece
General University Hospital "Attikon"
Chaïdári, , Greece
Metaxa Cancer Hospital, Athens
Piraeous, , Greece
Local Institution - 511
Rio, Patras, , Greece
Theageneio General Hospital, Thessaloniki
Thessaloniki, , Greece
Local Institution - 601
Busto Arsizio, , Italy
Ospedale di Busto Arsizio - ASST Valle Olona
Busto Arsizio, , Italy
Local Institution - 607
Genova, , Italy
Ospedale Policlinico San Martino - IRCCS
Genova, , Italy
Istituto Clinico Humanitas IRCCS
Milan, , Italy
Fondazione IRCCS Ca' Cranda, Ospedale Maggiore Policinico
Milan, , Italy
Local Institution - 614
Milan, , Italy
Istituto Europeo di Oncologia
Milan, , Italy
Azienda Ospedaliera Niguarda Ca' Granda
Milan, , Italy
Local Institution - 603
Milan, , Italy
Local Institution - 617
Padua, , Italy
Azienda Ospedaliera di Padova - U.O.C. di Gastroenterologia
Padua, , Italy
Local Institution - 613
Padua, , Italy
Azienda Ospedaliero - Universiaria di Parma
Parma, , Italy
Amyloidosis Research & Treatment Center, Fondazione Irccs Policlinico San Matteo
Pavia, , Italy
Local Institution - 609
Pavia, , Italy
Local Institution - 610
Pisa, , Italy
Azienda Ospedaliero Universitaria Pisana
Pisa, , Italy
Arcispedale Santa Maria Nuova - AUSL Reggio Emilia
Reggio Emilia, , Italy
Local Institution - 602
Reggio Emilia, , Italy
Infermi Hospital
Rimini, , Italy
Local Institution - 605
Rimini, , Italy
Policlinico Umberto I , Universita La Sapienza
Roma, , Italy
Local Institution - 611
Rome, , Italy
Local Institution - 608
Siena, , Italy
Universita di Siena -Azienda Ospedaliera Universitaria Senese-Policlincio Santa Maria Alle Scotte
Siena, , Italy
Azienda Ospedaliera Citta della Salute e della Scienza di Torino
Torino, , Italy
Local Institution - 616
Torino, , Italy
Presidio Ospedaliero Molinette - A.O.U. Citta della Salute e della Scieza
Torino, , Italy
Ospedale Dell'Angelo Di Mestre
Venezia, , Italy
Local Institution - 606
Venezia - Mestre, , Italy
HagaZiekenhuis van Den Haag - Juliana Kinderziekenhuis (JKZ) - Leyweg
The Hague, , Netherlands
Local Institution - 401
The Hague, , Netherlands
Local Institution - 204
Alava, , Spain
Hospital universitario de Alava
Alava País Vasco, , Spain
Hospital Universitario 12 de Octubre
Madrid, , Spain
Local Institution - 207
Madrid, , Spain
Local Institution - 201
Málaga, , Spain
Hospital Regional Universitario Carlos Haya
Málaga, , Spain
Hospital de Orense
Ourense, , Spain
Local Institution - 206
Ourense, , Spain
Local Institution - 202
Salamanca, , Spain
Hospital Clínico Universiatrio de Salamanca
Salamanca, , Spain
Local Institution - 209
Santa Cruz de Tenerife, , Spain
Local Institution - 205
Seville, , Spain
Nuestra Senora de Valme
Seville, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1213-1816
Identifier Type: REGISTRY
Identifier Source: secondary_id
EUPAS23366
Identifier Type: REGISTRY
Identifier Source: secondary_id
CC-5013-MCL-005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.